Carlsmed, Inc. (CARL)
$13.85-4.28%Close
SELLRECOVERY · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $377M
- Beta
- 2.09
- P/E (TTM)
- -10.18
- Short % float
- 11.63%
- Days to cover
- 14.3
- SI change
- -2.3%
- 1W
- -3.69%
- 1M
- -9.06%
- vs SPY 1W
- -2.71%
- vs SPY 1M
- -10.93%
Industry peers
FMP comparable companies · ranked by market cap
- ISRGBUYIntuitive Surgical, Inc.$149.1BRECOVERYQ 29$422.06-0.43%
- ATECBUYAlphatec Holdings, Inc.$1.7BRECOVERYQ -0$10.82-3.51%
- ENOVSELLEnovis Corporation$1.1BRECOVERYQ 0$18.99-2.21%
- SIBNBUYSI-BONE, Inc.$873MBULLQ 5$19.68-1.07%
- KIDSSELLOrthoPediatrics Corp.$563MRECOVERYQ 10$21.93+1.46%
- SSIISELLSS Innovations International, Inc.$510MCRISISQ 16$2.55+5.88%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CARL?
- LOPJLB’s latest quantitative signal on Carlsmed, Inc. (CARL) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is CARL in?
- Carlsmed, Inc. (CARL) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Carlsmed, Inc. (CARL) do?
- Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, an…